Literature DB >> 9570960

A microdeletion of D6S305 in a family of autosomal recessive juvenile parkinsonism (PARK2).

H Matsumine1, Y Yamamura, N Hattori, T Kobayashi, T Kitada, A Yoritaka, Y Mizuno.   

Abstract

A gene for autosomal recessive juvenile parkinsonism (ARJP; HGMW-approved symbol PARK2; MIM 600116) has recently been mapped to a 17-cM interval on chromosome 6q25.2-q27. We here report an inbred family with ARJP showing a perfect cosegregation with null allele for D6S305, which is a marker within the ARJP locus. We assigned the deletion within an interval between D6S1937 and AFMa155td9, which are 0 cM apart from each other and located on a single YAC clone. Two possibilities should be evaluated: (1) the deletion is polymorphic and linked to ARJP and (2) the deletion is pathogenic and contains both D6S305 and the ARJP gene (or a part of it). An exon search in a deleted segment or in the relatively small-sized genomic clones harboring D6S305 may enormously facilitate the cloning procedure of the ARJP gene.

Entities:  

Mesh:

Year:  1998        PMID: 9570960     DOI: 10.1006/geno.1997.5196

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  11 in total

Review 1.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

Review 2.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

Review 3.  The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity.

Authors:  David N Hauser; Christopher T Primiani; Mark R Cookson
Journal:  Curr Protein Pept Sci       Date:  2017       Impact factor: 3.272

Review 4.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 5.  Combination therapies: The next logical Step for the treatment of synucleinopathies?

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

Review 6.  Therapeutic approaches in Parkinson's disease and related disorders.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

Review 7.  Genetics of parkin-linked disease.

Authors:  Andrew B West; Nigel T Maidment
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

8.  Parkin deficiency prevents chronic ethanol-induced hepatic lipid accumulation through β-catenin accumulation.

Authors:  Dong Hun Lee; Mi Hee Park; Chul Ju Hwang; Youngsoo Kim; Dae Yeon Hwang; Sang Bae Han; Jin Tae Hong
Journal:  Cell Commun Signal       Date:  2019-08-22       Impact factor: 5.712

9.  PromoterLCNN: A Light CNN-Based Promoter Prediction and Classification Model.

Authors:  Daryl Hernández; Nicolás Jara; Mauricio Araya; Roberto E Durán; Carlos Buil-Aranda
Journal:  Genes (Basel)       Date:  2022-06-23       Impact factor: 4.141

Review 10.  Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy.

Authors:  Yu-Hsun Chang; Kung-Chi Wu; Horng-Jyh Harn; Shinn-Zong Lin; Dah-Ching Ding
Journal:  Cell Transplant       Date:  2018-04-25       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.